GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bioethics BOTH · USD

N/A · US listing · 🇺🇸 United States

Compare

0.01

—

Close of 30 Oct 2026, in USD

At a glance

Figures in USD, from our data supplier.

FY2025

Net income

−$176,955

FY2016FY2025

Free cash flow

−$150,429

FY2016FY2025

Shareholders' equity

−$931,220

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross profit————−$226−$286−$286−$285−$286−$60
Operating income−$122,817−$122,817−$50,442−$47,303−$59,367−$75,141−$70,033−$53,981−$48,220−$50,244
Net income−$176,955−$176,955−$97,149−$93,203−$107,183−$119,191−$101,915−$73,539−$64,223−$118,628
Diluted earnings per share-0.12-0.05-0.09-0.08-0.09-0.10-0.09-0.07-0.01-0.01

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$14,664$14,664$138$295$734$893$9,273$32,495$4,807$67,269
Cash and short-term investments$14,664—$138$295$734$667$8,761$31,697$1,724$65,900
Total liabilities$945,884$945,884$776,403$679,411$586,647$479,623$375,012$300,320$189,092$187,331
Debt$585,689—$442,734$420,584$395,384$365,116$303,518$250,919$167,000$160,000
Shareholders' equity−$931,220−$931,220−$776,265−$679,116−$585,913−$478,730−$365,739−$267,824−$184,285−$120,062
Shares outstanding1m3m1m1m1m1m1m1m9m13m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−$150,429−$150,429−$22,307−$25,639−$27,483−$68,694−$79,251−$43,946−$71,176−$42,324
Capital spending————−$3−$4———−$1,429
Free cash flow−$150,429−$150,429−$22,307−$25,639−$27,486−$68,698−$79,251−$43,946−$71,176−$43,753

Latest quarters

By quarter end

Jun 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023
Operating income−$33,334−$33,334−$39,284−$22,979−$27,221−$13,599−$10,004−$14,812
Net income−$48,287−$48,287−$53,083−$35,932−$39,653−$24,403−$22,300−$26,810
Diluted earnings per share-0.03-0.01-0.02-0.01-0.01-0.02-0.02-0.02
Total assets$14,664$14,664$17,153$10,168$93$138$483$473
Cash and short-term investments$14,664—$17,153$10,168$93—$483$473
Debt$585,689—$495,939$491,684$448,584—$436,884$433,184
Shareholders' equity−$931,220−$931,220−$862,933−$851,850−$815,918−$776,265−$751,862−$729,562

Growth per year

Compound annual rate

3 years5 years10 years
Operating income37.4%10.3%10.2%
Net income23.8%8.2%6.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-0.0-10.4-0.3-0.4-0.5-0.1-0.1-0.0-0.1

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-99%2693%-19%-38%534%175%-11%299%3025%248%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 10-to-1 reverse split · 2 Nov 2020

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.